Skip to content
Menu

Ekso Bionics Holdings, Inc. EKSO

Full chart Compare
Set alert

Price alert · EKSO

All alert types
15.90 USD 0.00 (+0.00%)

Jul 2, 2026, 3:24 PM EDT

15.75 Day range 18.12

52-week range unavailable

YTD
+84.03%
1 year
+165.00%

EKSO revenue history

Revenue is income from the company’s ordinary business activities.

12,799,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

FY 2012: 2,706,000USDFY 2013: 3,302,000USDFY 2014: 5,327,000USDFY 2015: 8,661,000USDFY 2016: 14,221,000USDFY 2017: 7,353,000USDFY 2018: 11,332,000USDFY 2019: 13,917,000USDFY 2020: 8,882,000USDFY 2021: 11,246,000USDFY 2022: 12,912,000USDFY 2023: 18,279,000USDFY 2024: 17,925,000USDFY 2025: 12,799,000USD

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-3112,799,000-5,126,000-28.60%
FY 20242024-12-3117,925,000-354,000-1.94%
FY 20232023-12-3118,279,0005,367,00041.57%
FY 20222022-12-3112,912,0001,666,00014.81%
FY 20212021-12-3111,246,0002,364,00026.62%
FY 20202020-12-318,882,000-5,035,000-36.18%
FY 20192019-12-3113,917,0002,585,00022.81%
FY 20182018-12-3111,332,0003,979,00054.11%
FY 20172017-12-317,353,000-6,868,000-48.29%
FY 20162016-12-3114,221,0005,560,00064.20%
FY 20152015-12-318,661,0003,334,00062.59%
FY 20142014-12-315,327,0002,025,00061.33%
FY 20132013-12-313,302,000596,00022.03%
FY 20122012-12-312,706,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-05-05T11:05:25.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.